This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
nearly tripled between 2016 and 2019, according to new national estimates from a cohort study in JAMA Network Open. The number of gender-affirming surgeries taking place in the U.S.
More than 31,000 staff – including pharmacists, mental health practitioners and social prescribers – have been recruited to work in general practice under the Additional Roles Reimbursement Scheme (ARRS) since 2019.
In 2019, amid an ever-worsening drug crisis, the federal government launched a research study with an ambitious goal: to lower opioid overdoses in participating communities by 40% using evidence-based interventions like distributing naloxone and providing access to addiction medications.
The software engineer’s disillusionment began in 2019, when her insurer, UnitedHealthcare, balked at covering physical therapy after she was hit by a car and could not walk. Like many Americans, Holden Karau said she was fed up with health insurance.
According to GlobalData’s Clinical Trials Database, during 2019-23, 51.8 The post APAC leads in asthma clinical trials between 2019-2023: GlobalData appeared first on Express Pharma. per cent of asthma trials were initiated in the APAC region.
Laura Perryman led Stimwave, which sold nerve stimulation devices to combat pain, from 2010 to 2019. STAT published new details about the Stimwave story in May, after former employees described how Perryman broke into Stimwave’s Florida headquarters to steal back devices after her termination in 2019.
Data was from 2019 in order to avoid the influence of the pandemic, when cancer diagnoses declined because of delayed care. The results were published in the American Cancer Society’s journal, CA: A Cancer Journal for Clinicians.
Where and when the Covid-19 pandemic began — in Wuhan, China in late 2019 — is well known. How it began is a matter of heated controversy. There are two competing hypotheses, one of which is hindering the process of scientific discovery and could hold back the development of vaccines and other antiviral agents in the U.S.
Around 6% of middle and high school students used vapes in 2024, down from 8% last year, and a record high of 20% in 2019, according to a survey released Thursday by the FDA and the CDC. The number of U.S. The vape brand Juul fueled this surge, but has since receded in popularity after FDA actions and legal challenges.
In just four years from the beginning of 2019 through 2022, according to the report, the number of Medicare patients receiving RPM increased tenfold, from 55,000 to 570,000. Remote patient monitoring has exploded since the pandemic. Medicare Advantage use increased 14 times over. Medicare Advantage use increased 14 times over.
More than 100,000 doctors have left private practice and become employees of hospitals and other corporate entities since 2019. Today, nearly three in four physicians are employees of larger health care entities or other corporations — a record high.
The decision is a stunning blow for a drug that was approved in 2019 , heralded as a new way to treat the inherited blood disorder. Pfizer said Wednesday that it was removing Oxbryta, a pill for the treatment of sickle cell disease, from all markets globally due to high risks of severe safety events, including deaths.
After his son Michael was diagnosed with a devastating, ultra-rare disease in 2019, Terry Pirovolakis dedicated himself to eradicating it. Pirovolakis, a Canadian IT director, recruited academics and raised $3 million to design a gene therapy.
Megan Hanson was eight weeks pregnant in 2019 when she experienced a miscarriage — her sixth consecutive loss in as many years. It felt particularly cruel after a second IVF transfer.
Meanwhile, medical notes in June 2019 showed Walter’s pain was maxing out the scales and that she could not dress herself, go to the bathroom, or even push a walker without help. Read the rest…
Vaccinations among children remain high, but the trend — with coverage dropping from about 95% in the 2019-2020 school year to 94% in 2020-2021 to 93% in 2021-2022, according to the data released Thursday — has health officials concerned. The percentage of U.S.
Laura Perryman led Stimwave, which sold nerve stimulation devices to combat pain, from 2010 to 2019, when the fraud came to light. The Securities and Exchange Commission on Tuesday charged the former CEO of Stimwave, a company that sold devices containing dummy pieces of plastic, with defrauding investors out of $41 million.
Results shared this week by the New Nets Project, an initiative funded by Unitaid and the Global Fund, highlighted a pair of second-generation bed nets tested in endemic areas between 2019 and 2022.
million employed people (both within the health care field and outside) observed from 2008 to 2019. While other research has examined the incidence of mental health issues and suicide risk among physicians, the same isn’t necessarily true of other health care professions.
WASHINGTON — A new trove of internal emails and other documents from the e-cigarette maker Juul reveals the company’s extensive behind-the-scenes efforts to promote its interests in Washington — a rare insight into the otherwise opaque methods corporations use to influence the government.
Researchers found an overall drop from 2010 and 2019 in death and disease linked to nitrogen dioxide (NO2), an air pollutant produced from fossil fuel burning, and fine particulate matter (PM2.5) Deaths attributable to PM2.5
Narayan, a professor of computer science at Princeton University, went viral in 2019 for a talk he gave at MIT on how to recognize overblown declarations about AI’s capabilities. Now he’s teamed up with his Ph.D. student Kapoor to publish the book “ AI Snake Oil ,” which came out Sep.
years in 2019 to 77 in 2020 and 76.1 At least partially as a consequence of over 1 million Covid-19 deaths, life expectancy in the U.S. has declined significantly over the past few years, falling from 78.8 in 2022 — undoing over two decades of progress. and Italy all enjoy a life expectancy of 80 years or more.
Merdad Parsey, who joined Gilead in 2019, will stay in his post until the first quarter of next year as the company looks for a successor, Gilead said in a press release Wednesday. Gilead has faced multiple setbacks in its attempt to move away from its stronghold in virology and into other areas like cancer.
Performed by researchers at Johns Hopkins University, the study found that between 2012 and 2019, 8.8% .
Now, a data analysis commissioned by STAT shows that the rate of postpartum sterilization is significantly higher in Americans with sickle cell disease than in those without. of births to unaffected mothers did.
Walmart had grand ambitions , back in 2019, to grow a network of cheaper primary care clinics attached to its ubiquitous stores. Those ambitions are now dead. The retail giant said Tuesday it is shuttering its 51 medical clinics across five states, as well as its virtual care offering.
The short history of CRISPR gene editing in humans has, with rare exception, been a history of triumphant progress: A patient apparently cured of sickle cell in 2019, six patients with toxic DNA knocked out of their liver last year, another six patients with a different strand of toxic liver DNA knocked out last week.
The 26,000-person, Phase 3 study, set to begin next year, will test a vaccine known as M72/AS01 that showed promising results from a smaller trial in 2019. The Gates Foundation unveiled plans Wednesday to fund a long-awaited trial for what, if proven effective, would be the first new tuberculosis vaccine in over a century.
This was also the highest rate of product discontinuations since 2019. These low prices also translated into more product discontinuations, which rose by 40% from 2022 to 2023, and from 100 drugs to 140 during that time. Continue to STAT+ to read the full story…
a decade after the chain announced it would implement a “No Antibiotics Ever” policy by 2019. The change will occur this spring at the slightly more than 3,000 Chick-fil-A locations around the U.S, The move comes amid changes by key suppliers.
Curaleaf, one the largest cannabis companies in the world, spent nearly 40% less on lobbying in the first half of 2023 than it did at its peak in 2019. Together, their spending on advocacy has dipped by more than 50% since 2019, back when federal weed lobbying was at its height. Read the rest…
In January 2019, provincial health authorities found that He’s human CRISPR experiments violated national regulations against gene-editing for reproductive purposes.
The company earned its first clearance from the Food and Drug Administration in 2016 , and went public in 2019 at a share price of $17. According to a press statement, Shockwave has treated 400,000 patients with this method globally.
The organization looked at four blockbuster drugs — Humira, Avastin, Rituxan, and Lantus — that had biosimilars launched between 2019 and 2023. years of unchallenged market presence.
hospitals and then tracked usage of seven antibiotics that were approved by the Food and Drug Administration between 2014 and 2019. They examined data spanning January 2016 through June 2021 at 619 U.S. Continue to STAT+ to read the full story…
Perryman led the company from 2010 to 2019. Stimwave was thus able to sell their devices for more money. From 2017 to 2020, the company sold nearly 8,000 devices with the fake component. “Laura Perryman callously created a dummy medical device component and told doctors to implant it into patients,” said U.S.
The researchers examined Medicare beneficiaries who were diagnosed with cancer and received treatment from 2014 through 2019. Overall, the proportion of patients who were prescribed so-called low-value drugs was higher when their oncologist accepted industry payments, according to the study, published in the BMJ.
The Food and Drug Administration approved 378 new drugs between 2010 and 2019, a big chunk of which were cancer medicines. Biotechnology companies played a big role in developing many of these new treatments, and their successes could partly be seen in the stock market, where biotech stocks soared.
This latest revision, known as the DSM-5-TR, was prepared between 2016 and 2019, and published in 2022. -based physicians who helped assemble a recent revision of the Diagnostic and Statistical Manual of Mental Disorders, which is often referred to as the bible of psychiatry.
Research dating back to the early 2000s has shown that ketamine and esketamine — which is derived from ketamine — are effective in cases of so-called treatment-resistant depression, and the nasal spray version of the drug was specifically approved for this indication in 2019. Read the rest…
The law, which was enacted in 2019, was designed to ensure that pharmacy benefit managers maintain access to a large number of pharmacies and do not steer patients to favored outlets, among other things.
In 2019, the American Associations of Physicists in Medicine concluded that the use of patient lead aprons should be discontinued as they were both unnecessary for safety and had the potential to jeopardize the quality of images. Other medical organizations have been making similar points for some time.
” What Bauman couldn’t have known was that roughly one year earlier, the Mount Sinai brain biopsies had set off alarm bells at the Food and Drug Administration, whose review had been triggered when a device manufacturer wrote to the agency in April 2019.
We organize all of the trending information in your field so you don't have to. Join 11,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content